Abstract

B-cell activating factor (BAFF) has a role in the maturation and maintenance of B cells and is associated with rheumatoid arthritis (RA). Here, we investigated whether tumor necrosis factor (TNF)-α-induced BAFF expression controls the survival of fibroblast-like synoviocytes (FLS) and whether their survival can be regulated by TNF-α-mediated upregulation of hypoxia-inducible factor (HIF)-1α using MH7A synovial cells transfected with the SV40 T antigen. More TNF-α-treated cells died compared with the control. Survival was increased by incubation with Z-VAD but inhibited after transfection with BAFF-siRNA. Both BAFF and HIF-1α expression were enhanced when MH7A cells were treated with TNF-α. TNF-α-induced BAFF expression decreased in response to HIF-1α-siRNA, whereas it increased under hypoxia or by overexpressing HIF-1α. The HIF-1α binding site on the BAFF promoter (−693 to −688 bp) was confirmed by chromatin immunoprecipitation assay to detect the −750 to −501 bp and −800 to −601 bp regions. The BAFF promoter increased in response to TNF-α treatment or overexpression of HIF-1α. However, TNF-α-induced BAFF expression and promoter activity decreased after treatment with the ERK inhibitor PD98059. Cell death was enhanced by PD98059 but was inhibited by overexpression of HIF-1α. Taken together, our results demonstrate that BAFF expression to control synovial cell survival was regulated by HIF-1α binding to the BAFF promoter, and suggest for the first time that HIF-1α might be involved in the production of inflammatory cytokines to regulate the physiological function of rheumatic FLS.

Highlights

  • Synovial hyperplasia and destruction of cartilage and bone are characteristics of rheumatoid arthritis (RA).[1]

  • Hypoxia-inducible factor-1α (HIF-1α) and BAFF are highly expressed in the joints of patients with RA, the relationship between these two hBAFF to GAPDH hBAFF to GAPDH

  • Synovial cells isolated from patients with RA were treated with tumor necrosis factor (TNF)-α for 1, 3, 6, 9, 12 h, and hBAFF expression was highest after the 6 h treatment

Read more

Summary

Introduction

Synovial hyperplasia and destruction of cartilage and bone are characteristics of rheumatoid arthritis (RA).[1]. Hypoxia-inducible factor-1α (HIF-1α), which is a regulator of angiogenesis, tumor growth, and glucose metabolism, is a wellknown transcription factor in cancers.[6,7] HIF-1α has an important role in the pathogenesis of RA.[8] High expression levels of HIF-1α are detected in the intimal synovium of patients with RA and are localized in the nucleus and cytoplasm of synoviocytes.[9] HIF-1α is normally degraded under normoxic conditions by the ubiquitin–proteasome pathway;[10] it accumulates under normoxic conditions in an inflammatory environment.[11] Various immune cells, including macrophages,. T cells, B cells, and plasma cells are recruited to the layer that lines the synovium during the progression of RA.[12] angiogenesis occurs, a malfunctioning vascular system maintains the hypoxic conditions.[13,14] Hypoxia-exposed macrophages produce additional quantities of proinflammatory cytokines, such as tumor necrosis factor (TNF)-α.15. Synovial macrophages and synoviocytes produce abundant pro- and anti-inflammatory cytokines, such as TNF-α, interleukin (IL)-1, IL-6, and transforming growth factor-β.3,16,17 TNF-α regulates other cytokines, destroys joint tissue,[18,19] and stabilizes HIF-1α under normoxic conditions.[20]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.